Tennessee research institute appoints Manoukian to lead cardiovascular initiative

The Sarah Cannon Research Institute (SCRI) in Nashville, Tenn., has named Steven V. Manoukian, MD, FACC, FSCAI, director of cardiovascular research, where he will lead a major cardiovascular research initiative at SCRI.

Manoukian was most recently director of interventional cardiology at Emory Crawford Long Hospital and assistant professor of medicine at Emory University School of Medicine in Atlanta. SCRI also noted that he is board-certified in internal medicine, cardiology and interventional cardiology.   

“This full-scale initiative is a reflection of SCRI’s commitment to a quality, comprehensive clinical research program. We believe that this program has the potential for significant growth under Dr. Manoukian’s leadership, both on a local and national level,” said Dee Anna Smith, CEO of SCRI.

Manoukian will also serve as medical director, cardiology services for the Hospital Corporation of America, a provider of healthcare services, SCRI said. 

SCRI said that Manoukian will practice clinical cardiology at Centennial Heart Cardiovascular Consultants in Nashville, Tenn., a provider of cardiology services in Middle Tennessee and one of SCRI’s strategic investigative sites.

Around the web

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.